Abstract
In an aging society with an increasing threat to higher brain cognitive functions due to dementia, it becomes imperative to identify new molecular remedies for supporting adult neurogenesis. Interleukin-6 (IL-6) is a promising cytokine that can support neurogenesis under conditions of neurodegeneration, and neuron replacement is eventually possible due to its agonistic acting soluble receptor sIL-6R. Here, we report that activation of the IL-6–signal transducer and activator of transcription 3 (STAT3) axis is neurogenic and has potential therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s disease (PD).
Similar content being viewed by others
Abbreviations
- AD:
-
Alzheimer’s disease
- AKT:
-
AKT (mouse Ak strain thymoma) serine/threonine kinase, protein kinase B (PKB)
- ALP:
-
Alkaline phosphatase
- AMPA:
-
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
- AP:
-
Action potential
- APC:
-
Allophycocyanin
- BDNF:
-
Brain-derived neurotrophic factor
- bFGF:
-
Basic fibroblast growth factor
- BMP:
-
Bone morphogenetic protein
- BSA:
-
Bovine serum albumin
- CD15:
-
Cluster of differentiation 15, 3-fucosyl-N-acetyl-lactosamine, SSEA-1 (stage-specific embryonic antigen 1)
- CD24:
-
Cluster of differentiation 24 or heat-stable antigen CD24 (HSA)
- CD44:
-
Cluster of differentiation 44, HCAM (homing cell adhesion molecule), Pgp-1 (phagocytic glycoprotein-1)
- CD184:
-
Cluster of differentiation 184, C-X-C chemokine receptor type 4 (CXCR-4)
- CD271:
-
Cluster of differentiation 271, LNGFR (low-affinity nerve growth factor receptor) or p75NTR (neurotrophin receptor p75)
- CH3:
-
Methyl-, methylation
- CNS:
-
Central nervous system
- CNTF:
-
Ciliary neurotrophic factor
- CREB:
-
cAMP-responsive element binding protein
- Cy:
-
Cyanine
- DAPI:
-
4′,6-Diamidino-2-phenylindole
- DMEM:
-
Dulbecco’s modified Eagle medium
- EDTA:
-
Ethylenediaminetetraacetic acid
- EGF:
-
Epidermal growth factor
- ERK:
-
Extracellular-regulated microtubule-associated protein kinase
- FACS:
-
Fluorescence-activated cell sorting
- FBS:
-
Fetal bovine serum
- FITC:
-
Fluorescein isothiocyanate
- FM:
-
Fibroblast media
- FOS:
-
Finkel-Biskis-Jinkins (FBJ) osteosarcoma (Fos) proto-oncogene, activator protein 1 (AP-1) transcription factor subunit
- GAB1:
-
GRB2-associated-binding protein 1
- GABA:
-
Gamma-aminobutyric acid
- GABAA-R:
-
Gamma-aminobutyric acid-A receptor
- GF:
-
Growth factor
- GFAP:
-
Glial fibrillary acidic protein
- i-Glu-R:
-
Ionotropic glutamate receptor
- gp130:
-
Glycoprotein 130
- GRB2:
-
Growth factor receptor bound protein 2
- HEPES:
-
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid
- ICC:
-
Immunocytochemistry
- IL-6:
-
Interleukin-6
- IL-6R:
-
Interleukin-6 receptor
- IL6ST:
-
Interleukin-6 signal transducing receptor subunit (gp130)
- iPSCs:
-
Induced pluripotent stem cells
- JAK:
-
Janus kinase
- JNK:
-
c-Jun N-terminal kinase
- JUN:
-
Jun proto-oncogene, activator protein 1 (AP-1) transcription factor subunit
- Klf4:
-
Kruppel-like factor 4
- Lif:
-
Leukemia inhibitory factor
- Lin28:
-
Lin-28 homolog
- L-Myc:
-
v-Myc avian myelocytomatosis viral oncogene lung carcinoma-derived homolog
- MAP2:
-
Microtubule-associated protein 2
- MAPK:
-
Microtubule-associated protein kinase
- MAPT:
-
Microtubule-associated protein tau
- MKI67:
-
Marker of proliferation Ki-67
- MYC:
-
Myelocytomatosis viral oncogene
- NB:
-
Neurobasal media
- NEUN:
-
Neuronal nuclei, RNA binding protein fox-1 homolog 3 (RBFOX3)
- NEAA:
-
Non-essential amino acids
- NHDF:
-
Normal human dermal fibroblast cells
- NMDA:
-
N-Methyl-d-aspartate
- NSC:
-
Neural stem cell
- OCT4:
-
POU class 5 homeobox 1 (POU5F1)
- P:
-
Passages
- p53:
-
Tumor protein 53
- PBS:
-
Phosphate buffer saline
- PD:
-
Parkinson’s disease
- PE:
-
Phycoerythrin cyanine
- PerCP:
-
Peridinin chlorophyll protein complex
- PFA:
-
Paraformaldehyde
- PI3K:
-
Phosphatidylinositol 3-kinase, and phosphatidylinositol-4,5-bisphosphate 3-kinase
- PODXL:
-
Podocalyxin-like proteins, also known as TRA-1-60 and TRA-1-81 antigens
- P/S:
-
Penicillin, streptomycin
- RAS:
-
Sarcoma virus oncogene (small G-protein)
- RMP:
-
Resting membrane potential
- SFK:
-
src-family kinase
- sgp130:
-
Soluble glycoprotein 130
- SHP1/2:
-
Protein tyrosine phosphatase, non-receptor type 6, -11 (Ptpn6/11)
- shRNA:
-
Short hairpin RNA
- sIL-6R:
-
Soluble interleukin-6 receptor
- SMAD:
-
Portmanteau of Sma (small) and Mad (mothers against decapentaplegic homolog)
- SOCS3:
-
Suppressor of cytokine signaling 3
- SOX2/6:
-
Sex-determining region Y (SRY)-box 2, -6
- SOS:
-
Son of sevenless protein
- SSEA3/4:
-
Stage-specific embryonic antigen 3, -4
- STAT3:
-
Signal transducer and activator of transcription 3
- TF:
-
Transcription factor
- TGFβ:
-
Transforming growth factor beta
- TRA-1-60/81:
-
Podocalyxin-like proteins (PODXL, TRA-1-60, and TRA-1-81 antigens)
- TRKB:
-
Tropomyosin receptor kinase B, neurotrophic receptor tyrosine kinase 2 (NTRK2)
- TRKB.T1:
-
Truncated TRKB (without kinase domain)
- TTX:
-
Tetrodotoxin
- TUBB3:
-
β-Tubulin isotype III (also TUJ1)
- VD:
-
Vascular dementia
- YAP:
-
Yes-associated protein
- Y-P:
-
Phosphorylated tyrosine
References
Nishikawa S, Goldstein RA, Nierras CR (2008) The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 9(9):725–729
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M et al (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8(5):409–412
Pramanik S, Sulistio YA, Heese K (2017) Neurotrophin signaling and stem cells—implications for neurodegenerative diseases and stem cell therapy. Mol Neurobiol. doi:10.1007/s12035-016-0214-7
Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86(4):1243–1254
Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15:797–819
Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254–1266
Feng Q, Wang YI, Yang Y (2015) Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia. Exp Ther Med 9(5):1695–1701
Wang XC, Qiu YH, Peng YP (2007) Interleukin-6 protects cerebellar granule neurons from NMDA-induced neurotoxicity. Sheng Li Xue Bao 59(2):150–156
Cafferty WB, Gardiner NJ, Das P, Qiu J, McMahon SB, Thompson SW (2004) Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 24(18):4432–4443
Gruol DL (2015) IL-6 regulation of synaptic function in the CNS. Neuropharmacology 96(Pt A):42–54
Hakkoum D, Stoppini L, Muller D (2007) Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J Neurochem 100(3):747–757
Gadient RA, Otten U (1994) Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett 182(2):243–246
Ming GL, Song H (2005) Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28:223–250
Thier M, Marz P, Otten U, Weis J, Rose-John S (1999) Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons. J Neurosci Res 55(4):411–422
Hirota H, Kiyama H, Kishimoto T, Taga T (1996) Accelerated nerve regeneration in mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J Exp Med 183(6):2627–2634
Ihara S, Nakajima K, Fukada T, Hibi M, Nagata S, Hirano T, Fukui Y (1997) Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6. EMBO J 16(17):5345–5352
Sterneck E, Kaplan DR, Johnson PF (1996) Interleukin-6 induces expression of peripherin and cooperates with Trk receptor signaling to promote neuronal differentiation in PC12 cells. J Neurochem 67(4):1365–1374
Wu YY, Bradshaw RA (1996) Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J Biol Chem 271(22):13023–13032
Marz P, Herget T, Lang E, Otten U, Rose-John S (1997) Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation. Eur J Neurosci 9(12):2765–2773
Ihara S, Iwamatsu A, Fujiyoshi T, Komi A, Yamori T, Fukui Y (1996) Identification of interleukin-6 as a factor that induces neurite outgrowth by PC12 cells primed with NGF. J Biochem 120(5):865–868
Abeyama K, Kawano K, Nakajima T, Takasaki I, Kitajima I, Maruyama I (1995) Interleukin 6 mediated differentiation and rescue of cell redox in PC12 cells exposed to ionizing radiation. FEBS Lett 364(3):298–300
Nakafuku M, Satoh T, Kaziro Y (1992) Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 267(27):19448–19454
Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y (1988) Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol 8(8):3546–3549
Islam O, Gong X, Rose-John S, Heese K (2009) Interleukin-6 and neural stem cells: more than gliogenesis. Mol Biol Cell 20(1):188–199. doi:10.1091/mbc.E08-05-0463
Bowen KK, Dempsey RJ, Vemuganti R (2011) Adult interleukin-6 knockout mice show compromised neurogenesis. Neuroreport 22(3):126–130
Marz P, Otten U, Rose-John S (1999) Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors. Eur J Neurosci 11(9):2995–3004
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872
Hussein SM, Nagy AA (2012) Progress made in the reprogramming field: new factors, new strategies and a new outlook. Curr Opin Genet Dev 22(5):435–443
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27(3):275–280
Morizane A, Doi D, Kikuchi T, Nishimura K, Takahashi J (2011) Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res 89(2):117–126
Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP, Vidal JG, Mu Y et al (2011) Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 6(3):e17540
Mishra M, Akatsu H, Heese K (2011) The novel protein MANI modulates neurogenesis and neurite-cone growth. J Cell Mol Med 15(8):1713–1725. doi:10.1111/j.1582-4934.2010.01134.x
Mishra M, Heese K (2011) P60TRP interferes with the GPCR/secretase pathway to mediate neuronal survival and synaptogenesis. J Cell Mol Med 15(11):2462–2477. doi:10.1111/j.1582-4934.2010.01248.x
Guez-Barber D, Fanous S, Harvey BK, Zhang Y, Lehrmann E, Becker KG, Picciotto MR, Hope BT (2012) FACS purification of immunolabeled cell types from adult rat brain. J Neurosci Methods 203(1):10–18
Park SY, Yoon SN, Kang MJ, Lee Y, Jung SJ, Han JS (2017) Hippocalcin promotes neuronal differentiation and inhibits astrocytic differentiation in neural stem cells. Stem Cell Reports 8(1):95–111
Hogg RC, Chipperfield H, Whyte KA, Stafford MR, Hansen MA, Cool SM, Nurcombe V, Adams DJ (2004) Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci 19(9):2410–2420
Johnson MA, Weick JP, Pearce RA, Zhang SC (2007) Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci 27(12):3069–3077
Toda H, Takahashi J, Mizoguchi A, Koyano K, Hashimoto N (2000) Neurons generated from adult rat hippocampal stem cells form functional glutamatergic and GABAergic synapses in vitro. Exp Neurol 165(1):66–76
Owens DF, Kriegstein AR (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3(9):715–727
Shen JM, Huguenard JR, Kriegstein AR (1988) Development of GABA responsiveness in embryonic turtle cortical neurons. Neurosci Lett 89(3):335–341
Hennou S, Khalilov I, Diabira D, Ben-Ari Y, Gozlan H (2002) Early sequential formation of functional GABA(A) and glutamatergic synapses on CA1 interneurons of the rat foetal hippocampus. Eur J Neurosci 16(2):197–208
Lujan R, Shigemoto R, Lopez-Bendito G (2005) Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130(3):567–580
Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190(Suppl 1):S8–21
Kriegstein A, Alvarez-Buylla A (2009) The glial nature of embryonic and adult neural stem cells. Annu Rev Neurosci 32:149–184
Petri S, Krampfl K, Dengler R, Bufler J, Weindl A, Arzberger T (2002) Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra. J Comp Neurol 452(4):360–366
Tepper JM, Lee CR (2007) GABAergic control of substantia nigra dopaminergic neurons. Prog Brain Res 160:189–208
Ling ZD, Potter ED, Lipton JW, Carvey PM (1998) Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149(2):411–423
Gomi M, Aoki T, Takagi Y, Nishimura M, Ohsugi Y, Mihara M, Nozaki K, Hashimoto N et al (2011) Single and local blockade of interleukin-6 signaling promotes neuronal differentiation from transplanted embryonic stem cell-derived neural precursor cells. J Neurosci Res 89(9):1388–1399
Oh J, McCloskey MA, Blong CC, Bendickson L, Nilsen-Hamilton M, Sakaguchi DS (2010) Astrocyte-derived interleukin-6 promotes specific neuronal differentiation of neural progenitor cells from adult hippocampus. J Neurosci Res 88(13):2798–2809
Pratt L, Ni L, Ponzio NM, Jonakait GM (2013) Maternal inflammation promotes fetal microglial activation and increased cholinergic expression in the fetal basal forebrain: role of interleukin-6. Pediatr Res 74(4):393–401
Chucair-Elliott AJ, Conrady C, Zheng M, Kroll CM, Lane TE, Carr DJ (2014) Microglia-induced IL-6 protects against neuronal loss following HSV-1 infection of neural progenitor cells. Glia 62(9):1418–1434
Cao F, Hata R, Zhu P, Nakashiro K, Sakanaka M (2010) Conditional deletion of Stat3 promotes neurogenesis and inhibits astrogliogenesis in neural stem cells. Biochem Biophys Res Commun 394(3):843–847
Nakanishi M, Niidome T, Matsuda S, Akaike A, Kihara T, Sugimoto H (2007) Microglia-derived interleukin-6 and leukaemia inhibitory factor promote astrocytic differentiation of neural stem/progenitor cells. Eur J Neurosci 25(3):649–658
Taga T, Fukuda S (2005) Role of IL-6 in the neural stem cell differentiation. Clin Rev Allergy Immunol 28(3):249–256
Vallieres L, Campbell IL, Gage FH, Sawchenko PE (2002) Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci 22(2):486–492
Takizawa T, Yanagisawa M, Ochiai W, Yasukawa K, Ishiguro T, Nakashima K, Taga T (2001) Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3. Cytokine 13(5):272–279
Galli R, Pagano SF, Gritti A, Vescovi AL (2000) Regulation of neuronal differentiation in human CNS stem cell progeny by leukemia inhibitory factor. Dev Neurosci 22(1–2):86–95
Foshay KM, Gallicano GI (2008) Regulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fate. Stem Cells Dev 17(2):269–278
Snyder M, Huang XY, Zhang JJ (2011) Stat3 is essential for neuronal differentiation through direct transcriptional regulation of the Sox6 gene. FEBS Lett 585(1):148–152
Cheng X, Jin G, Zhang X, Tian M, Zou L (2011) Stage-dependent STAT3 activation is involved in the differentiation of rat hippocampus neural stem cells. Neurosci Lett 493(1–2):18–23
Ng YP, Cheung ZH, Ip NY (2006) STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem 281(23):15636–15644
Yang P, Wen H, Ou S, Cui J, Fan D (2012) IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp Neurol 236(1):19–27
Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X (2006) Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 172(2):245–257
Galun E, Rose-John S (2013) The regenerative activity of interleukin-6. Methods Mol Biol 982:59–77
Schafer KH, Mestres P, Marz P, Rose-John S (1999) The IL-6/sIL-6R fusion protein hyper-IL-6 promotes neurite outgrowth and neuron survival in cultured enteric neurons. J Interf Cytokine Res 19(5):527–532
Kikuchi T, Morizane A, Doi D, Okita K, Nakagawa M, Yamakado H, Inoue H, Takahashi R et al (2017) Idiopathic Parkinson’s disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains. J Neurosci Res. doi:10.1002/jnr.24014
Xiao B, Ng HH, Takahashi R, Tan EK (2016) Induced pluripotent stem cells in Parkinson’s disease: scientific and clinical challenges. J Neurol Neurosurg Psychiatry 87(7):697–702
Stoker TB, Barker RA (2016) Cell therapies for Parkinson’s disease: how far have we come? Regen Med 11(8):777–786
Pen AE, Jensen UB (2017) Current status of treating neurodegenerative disease with induced pluripotent stem cells. Acta Neurol Scand 135(1):57–72
Acknowledgements
This study was supported by Hanyang University by providing a scholarship to Y.A.S. and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2009178).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Electronic Supplementary Material
ESM 1
(PDF 3134 kb)
Rights and permissions
About this article
Cite this article
Sulistio, Y.A., Lee, H.K., Jung, S.J. et al. Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation. Mol Neurobiol 55, 3513–3522 (2018). https://doi.org/10.1007/s12035-017-0594-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-017-0594-3